NCT00621647View on ClinicalTrials.gov

Seroquel- Agitation Associated With Dementia

PHASE3CompletedINTERVENTIONAL
Enrollment

333

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

November 30, 2003

Study Completion Date

November 30, 2003

Conditions
Alzheimer's DiseaseVascular Dementia
Interventions
DRUG

Quetiapine Fumarate

DRUG

Quetiapine Fumarate

DRUG

Placebo

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT00621647 - Seroquel- Agitation Associated With Dementia | Biotech Hunter | Biotech Hunter